This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Astrazeneca Ab. Active years: 2010-2026.
Company Filing History:
Years Active: 2010-2026
Title: Björn Holm - Innovator in Pharmaceutical Compounds
Introduction
Björn Holm is a notable inventor based in Mölndal, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on novel compounds.
Latest Patents
Björn Holm holds a patent for MGluR5 modulators. This invention is directed to novel compounds, a process for their preparation, their use in therapy, and pharmaceutical compositions comprising these novel compounds. He has 1 patent to his name.
Career Highlights
Björn Holm is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca focuses on developing new therapeutic solutions that can improve patient outcomes.
Collaborations
Throughout his career, Björn has collaborated with talented individuals such as Andreas Christer Wallberg and Karolina Nilsson. These collaborations have contributed to the advancement of his research and innovations.
Conclusion
Björn Holm's contributions to the pharmaceutical industry through his innovative patents and collaborations highlight his role as a key inventor in the field. His work continues to pave the way for new therapeutic options.